Result Summary for 103514
|Clinical Study ID:||103514|
|Official Title:||Phase 3, open, age-stratified study to assess immunogenicity & safety of GSK Biologicals' HPV-16/18 vaccine administered intramuscularly according to 3-dose schedule (0,1,6 months) in healthy female subjects aged 15 - 55 years and long term follow-up|
|Study Indications or Diseases:||
|Generic Name:||Human Papillomavirus Types 16 and 18 Vaccine|
|Approved Drug Label:||http://www.gsk.com/products.html|
|Results Summary:|| Click
here to download result summary.
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.